This has led to exploring other alternatives, for example, related to more efficient delivery of drugs across the blood-brain barrier with the use of nanotechnology [41] and to the use of vaccines against protein aggregates characteristic of AD (tau or β-amyloid [42]). Here, MAPT is linked to Alzheimer disease.